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 2
ABSTRACT 
Background 
Persistent post-concussional symptoms (PCS) can be a source of distress and disability following 
traumatic brain (TBI). Such symptoms have been viewed as difficult to treat but may be amenable to 
psychological approaches such as cognitive behaviour therapy (CBT).  
Objectives 
To evaluate the effectiveness of a 12-session individualised, formulation-based CBT program.  
Method 
Two-centre randomised waiting list controlled trial with 46 adults with persistent PCS after 
predominantly mild-to-moderate TBI (52% with PTA ≤ 24 hours), but including some with severe 
TBIs (20% with PTA > 7 days). 
Results 
Improvements associated with CBT were found on the primary outcome measures relating to quality 
of life (using the Quality of Life Assessment Schedule and the Brain Injury Community 
Rehabilitation Outcome scale). Treatment effects after covarying for treatment duration were also 
found for postconcussional symptoms and several secondary outcomes including measures of anxiety 
and fatigue (but not depression or PTSD). Improvements were more apparent for those completing 
CBT sessions over a shorter period of time, but were unrelated to medicolegal status, injury severity 
or length of time since injury.  
Conclusions 
This study suggests that CBT can improve quality of life for adults with persistent PCS, and 
potentially reduce symptoms for some, in the context of outpatient brain injury rehabilitation services. 
Trial registration 
ISRCTN49540320 
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 3
INTRODUCTION 
Traumatic brain injury (TBI) is associated with a range of cognitive, emotional and physical 
symptoms. In the context of mild TBI (MTBI), the label postconcussional symptoms (PCS) is 
commonly applied to reported problems including difficulty with concentration and memory, 
irritability, depression and anxiety, and physical symptoms such as fatigue, headaches, dizziness.[1] 
Such symptoms are common in the first few days or weeks after injury, but typically improve and 
remit. However, in a minority these symptoms persist.[2] When lasting beyond three months post-
MTBI, they are viewed as problematic and likely to be chronic[3] or even worsen[4] and have 
previously been viewed as resistant to treatment.[5] Although the term PCS is typically associated 
with MTBI, the same constellation of symptoms can be reported after more severe injuries, although 
their aetiology and course may differ.[6] With this caveat, “PCS” will be used here, operationally, to 
describe the set of self-reported persistent postconcussional or PCS-like symptoms across a spectrum 
of TBI severity. 
 
There is growing evidence indicating that psychosocial factors influence the persistence of PCS after 
MTBI [7-11] and overlapping symptoms or outcomes such as anxiety, depression and employment 
status in studies including individuals with severe TBIs.[12,13] Lishman[14] suggested that while 
direct effects of brain injury may contribute towards early PCS, persistence may increasingly involve 
broader psychosocial factors and mechanisms. Similar diathesis-stressor models have been described 
[15,16] where symptoms are maintained via “vicious cycles” involving factors indirectly related or 
independent of any direct effects of brain injury. If this is the case then psychological approaches to 
management may be applicable and effective in helping address or manage symptoms across a 
continuous spectrum of TBI severity, including more-than-mild TBIs, acknowledging that the 
likelihood and degree of persisting difficulties related to brain injury increases as injury severity 
increases.  
Although supported by expert opinion, [17] evidence for the effectiveness of cognitive-behavioural 
therapy (CBT) to tackle persistent PCS is limited.[18] Trials incorporating CBT for individuals with 
TBI have tended to focus on specific symptoms such as depression,[19] insomnia,[20] or 
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 4
headache.[21] Typically using single-case or case series designs, results do point to possible 
improvements in these domains using CBT. There is some support for prophylactic interventions in 
patients at risk for persistent PCS in some[22] but not all studies.[23] Only one RCT has specifically 
focussed on persistent PCS [24] randomising 20 individuals with mild-moderate TBI (seen on average 
between 5 and 6 years post-injury) to a waiting list group or an intensive neuropsychological 
rehabilitation treatment program (5 hours per week for 11 weeks) combining CBT and cognitive 
remediation. Improvements were demonstrated on a global symptom measure, in symptoms 
associated with anxiety and depression, and some measures of cognitive functioning (although not 
subjective functioning). The relative contribution of the CBT and cognitive remediation components 
could not be assessed and it is unclear whether improvement could be achieved using CBT alone. 
 
The current study tested the impact of individual, formulation-driven CBT, without explicit cognitive 
remediation or cognitive rehabilitation.  The study was conducted as a preliminary RCT (with waiting 
list control) delivered in the context of two outpatient brain injury services. Eligibility criteria were 
designed to help ensure that the results would be generalizable to routine clinical practice. It was 
predicted that individuals would report reduced PCS and greater quality of life and health status after 
receiving CBT when compared with those in the control group. Supplementary analyses examined the 
impact on specific domains of PCS and quality of life, such as symptoms associated with depression, 
PTSD, pain and fatigue. 
 
METHODS 
Participants were randomised to the immediate Intervention group or waiting list Control group: the 
latter were offered treatment at the end of the waiting list period. There was no financial incentive or 
other compensation offered to participate in the study. Ethical approval was received by the 
committees overseeing the two trial sites. The trial was registered with the International Standard 
Randomised Controlled Trial Number Register (ISRCTN49540320). 
 
Recruitment 
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 5
Participants were recruited through consecutive out-patients referrals to two National Health Service 
secondary/tertiary care brain injury clinics at the Lishman Brain Injury Unit at South London and 
Maudsley NHS Foundation Trust, London, UK, and the Brain Injury Rehabilitation Unit, at Edgware 
Community Hospital, London, UK, between March 2003 and June 2009.  
 
Inclusion criteria were age between 18 and 65 at the time of initial assessment; evidence for (at 
minimum) a mild traumatic brain injury (MTBI)[25] at least six months before; and symptoms 
consistent with the ICD-10 criteria for Postconcussional Disorder (F07.2), as laid out in the 
Diagnostic Criteria for Research (DCR-10).[1] 
 
Exclusion criteria were: non-fluent English; Mini Mental State Exam[26] scores of less than 20 and/or 
Frontal Assessment Battery[27] scores of less than 10; moderate-severe physical disability 
(Barthel[28] score less than 15); previous receipt of 4 or more sessions of CBT after their TBI; other 
neurological disorder independent of the TBI (e.g. non-post-traumatic epilepsy); drug/alcohol misuse 
meeting ICD-10[29] criteria for a dependence syndrome (F1x.2); and clinically-assessed risk of self-
harm or severe psychiatric illness necessitating involvement of a Community Mental Health Team. 
 
Potential participants were screened for eligibility at an initial neuropsychiatric or multidisciplinary 
assessment, and offered a neuropsychological assessment and feedback session if this had not been 
completed previously. In the absence of consistent contemporaneous injury severity information from 
GCS or post-traumatic amnesia (PTA), the latter was retrospectively estimated at initial assessment(s) 
using the Rivermead protocol[30] which provides reasonable accuracy in terms of overall categorical 
classification of TBI severity.[31] Median PTA duration was 24 hours (Intervention: 30 hours, range 
0-1440 hours; Control: 16 hours, range 0-1800 hours).  
 
All eligible participants were invited to participate. After providing informed consent, but before 
randomization, participants completed the first (T1) set of outcome measures with the study therapist. 
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 6
Their general practitioner was requested that, as far as possible, any psychoactive medications were 
kept constant, and to inform the project team of any changes. 
 
Randomisation 
Independent randomization was carried out independently by a Clinical Trials Unit using four pre-
planned categorical variables for minimisation with an 80/20 minimised/random weighting applied 
case-by-case: site (Maudsley: Edgware); injury severity (PTA ≤ 24 hours [mild]: > 24hrs PTA ≤ 7 
days [moderate]: PTA > 7 days [severe]); length of time since injury (6 to < 12 months: 12-24 months 
>24 months), and medicolegal status (previous or current involvement, vs. no previous/current 
involvement). A minimum of 40 participants was recommended for randomization with 4 
minimization factors: sample size was determined on that basis, with a minimum of 20 participants 
per group.  
 
Flow through the study is shown in Figure 1, with 26 randomised to the Intervention arm and 20 to 
the Control arm. Median interval between injury and randomization was 25 months (Intervention: 28 
months, range 6-171); Control: 23 months, range 8-175). Demographic details of the participants are 
shown in Table 1. There were no significant differences between the two groups at T1 on any 
minimisation variables (all p’s > 0.4) or gender (χ2 (1)=0.450; p=0.502), age (t (1)=-0.86; p=0.393), 
education (t (1)=-0.109; p=0.914) or current occupational level (χ2 (2)=0.073; p=0.964) (Table 1). 
PTA duration did differ between the groups (Mann-Whitney U=225.5; p=0.44). 
Table 1: Individual demographic and injury characteristics at T1 (before randomisation) 
 
Intervention Group 
(n = 26) 
Waiting List Group 
(n = 20) 
Total sample 
(N = 46) 
Age 40.1±10.3 43.1±13.1 41.4±11.6 
Gender (male) 58% (15) 50% (10) 54% (25) 
Education (years) 15.0 ± 2.8 15.1 ± 3.4 15.0 ± 3.0 
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 7
Qualifications (or equivalent) obtained        
 No qualifications 4% (1) 10% (2) 7% (3) 
 GCSE 31% (8) 20% (4) 26% (12) 
 A-Level 12% (3) 25% (5) 17% (8) 
 Undergraduate degree 35% (9) 20% (4) 28% (13) 
 Postgraduate degree 19% (5) 25% (5) 22% (10) 
Employment status       
 Full-time 27% (7) 30% (6) 28% (13) 
 Part-time 19% (5) 20% (4) 20% (9) 
 Unemployed 54% (14) 50% (10) 52% (24) 
Injury Type       
 Road traffic accident 62% (16) 55% (11) 59% (27) 
 Assault 12% (3) 10% (2) 11% (5) 
 Other 27% (7) 35% (7) 30% (14) 
PTA duration (hours) 170 ± 354 138 ± 399 156 ± 370 
 ≤ 24 hours [mild] 46% (12) 60% (12) 52% (24) 
 > 24 hours, ≤ 7 days [moderate] 31% (8) 25% (5) 28% (13) 
 >  7 days [severe] 23% (6) 15% (3) 20% (9) 
Time since injury (months) 42 ± 39 34 ± 38 39 ± 39 
 6 – 12 months 23% (6) 35% (7) 28% (13) 
 > 12 months, ≤ 24 months 23% (6) 15% (3) 20% (9) 
 > 24 months 54% (14) 50% (10) 52% (24) 
Previous or current involvement in 
litigation (yes) 
73% (19) 70% (14) 72% (33) 
 Current litigation (yes) 50% (13) 40% (8) 46% (21) 
Site of treatment (% Maudsley) 85% (22) 90% (18) 87% (40) 
Values are shown as either mean ± SD or percentage (n) 
 
Outcome Measures 
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 8
Outcome measures are shown in Table 2. Three co-primary outcome measures examined broad 
aspects of PCS and their impact. Six secondary outcome measures were used to examine more 
specific domains (such as those relating to depression or fatigue), as well as a supplementary quality 
of life scale.  
 
Table 2: Primary and secondary outcome measures 
Primary outcome measures Description Index (cut-off if applicable) 
Rivermead Post Concussion Symptoms 
Questionnaire (RPQ)[32] 
16-item measure of the severity 
and impact of PCS 
Total score (>12)[33] 
Brain Injury Community Rehabilitation 
Outcome scale (BICRO-39)[34] 
39-item measure of functioning 
and disability 
Total and subscale scores 
Quality of Life Assessment Schedule 
(QOLAS)[35] 
10-item personalized measure of 
quality of life and health status. 
Total score 
Secondary outcome measures   
Hospital Anxiety and Depression Scale 
(HADS)[36]  
 
14-item measure of anxiety and 
depression 
Anxiety (HADS-A) and 
Depression (HADS-D) 
subscale totals (>10). 
Impact of Event Scale - Revised (IES-
R)[37]  
 
22-item measure of PTSD Total score (>32)[38] 
Checklist of Individual Strength 
(CIS20R)[39] 
 
20-item measure of fatigue Total score (cut-off of ≥40 for 
the “subjective fatigue” 
subscale)[40] 
McGill Pain Questionnaire (MPQ)[41]  
 
Multi-dimensional assessment 
of pain 
Present Pain Intensity 
State-Trait Anger Expression Inventory-2 
(STAXI-2)[42] 
 
57-item measure of state/trait 
anger and anger expression 
Anger Expression Index, raw 
score 
EuroQoL from EQ-5D[43]  Visual analogue scale of global  
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 9
 subjective health rating (0-100). 
 
 
For the QOLAS, individuals are asked to identify their two greatest problems/issues in each of five 
different domains: physical health, cognitive problems, psychological issues, social issues, and daily 
activities. Each problem is rated on a 0-5 scale (from to “no problem” to “it could not be worse”) and 
the items summed. Validity, reliability and sensitivity to change for the QOLAS has been shown in 
other clinical populations.[35,44] It was judged particularly suitable for assessing PCS due to the 
potential heterogeneity of symptoms, and to help identify those symptoms most troubling to an 
individual and prioritise them during treatment.. Blind expert rating of individual responses in the 
physical, psychological and cognitive domains indicated that 84.2 % were directly/closely related to 
DCR-10 description of Postconcussional Disorder;[1] 10.2% as indirectly/partially related; and only 
5.5% not apparently/obviously related. 
 
With the exception of the EuroQol, higher scores on all of the outcome measures indicate a greater 
degree of symptoms, distress or impact. All measures were self-report and therefore non-blind. 
Assessments were completed prior to randomization (T1) and at the end of treatment (Intervention 
arm) or after 4-months (Control arm) (T2).  
 
Treatment methods: CBT format and content 
The planned intervention comprised 12 weekly one-hour sessions of individual CBT, but the protocol 
allowed for longer inter-session intervals. Treatment was provided by the same therapist (SP), a 
clinical neuropsychologist with previous experience of CBT in the context of TBI, depression and 
chronic fatigue syndrome.  
 
Given the heterogeneity of PCS, an individualised, formulation-driven approach within a semi-
structured protocol was used. Agenda-based sessions, collaborative target-setting and homework tasks 
were central features of treatment. Details of the intervention are described in more detail elsewhere 
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 10
[16] and in the supplementary online information. A session structure similar to that described by 
Miller and Mittenberg[45] was used. The first three sessions were broadly focussed on problem 
identification, psychoeducation based on a range of sources, socialising the patient to the CBT model, 
and formulation. Sessions 4-12 focussed on the individual target problems identified collaboratively 
with the therapist. In the final 3 sessions, time was increasingly focussed on relapse prevention and 
how to maintain therapeutic gains. Copies of the protocol and booklets are available from the authors 
on request. 
 
Central to individual CBT case formulations were (a) that persistent PCS could be maintained or 
exacerbated by vicious cycles[15] (b) that these cycles could be understood by reciprocal relationships 
between thoughts, emotions and actions, and (c) that alleviation in symptoms, associated distress and 
functional limitations was possible by changing thinking and behaviour. Whilst it was recognised in 
the treatment protocol that persistent cognitive difficulties attributable to the injury might exist for 
some individuals (especially for more-than-mild injuries),[46] no attempt was made to provide 
explicit cognitive remediation or rehabilitation. With increasing injury severity and more-than-mild 
TBIs, psychological mechanisms were framed as likely to still play an important role in maintaining 
ongoing symptoms via “vicious cycles”, presenting a therapeutic target for CBT to help reduce 
symptoms and their impact. Overt resistance to psychologically-orientated treatment did not appear to 
be a common issue for individuals completing the initial screening assessments but who did not wish 
to take part in the trial. Although the reasons for declining participation were not systemically 
collected, of the 21 individuals who declined, 9 were prepared to be referred for CBT outside the trial, 
and another 5 cited distance as an obstacle to attending regular treatment sessions. 
 
Control waiting list group 
Individuals randomised to the Control arm received a letter following randomisation with the date of 
an out-patient appointment to complete the T2 measures. Patients in this arm did not receive any form 
of additional information or psychological intervention from the service for the period that they were 
on the waiting list. 
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 11
 
Participants in both groups were offered clinical follow-up after their CBT sessions finished.  
 
Statistical Analyses 
Analysis was planned on an intention-to-treat basis. In practice almost all individuals in the 
Intervention arm completed their course of CBT and T2 outcome measures: three individuals stopped 
after 8, 9 and 10 sessions respectively due to significant symptom improvement and a lack of 
outstanding treatment targets. Only one patient discontinued treatment after 6 sessions and was lost to 
follow up due to difficulties attending the sessions. No attempt was made to impute missing data for 
this one case. 
 
Data were double-entered from the completed paper forms on to computer, and analysed using SPSS 
15.0. For the main treatment effects, analysis of covariance (ANCOVA) was used,[47] comparing 
outcome between groups at T2 with T1 as a covariate: effect sizes are shown using partial eta squared 
and an estimate of Cohen’s d (dˆ ), calculated as the mean difference between the contrasts divided by 
square root of the mean squared error.  
 
It was predicted that the Intervention arm would report fewer symptoms and better quality of life after 
CBT compared with those in the Control arm after their time on the waiting list. Given the 
exploratory nature of the study and the paucity of evidence from relevant previous controlled trials, 
primary outcome measures were analysed independently without correction for multiple comparisons. 
For secondary outcomes, corrections for multiple comparisons were applied using the Benjamini and 
Hochberg method.[48] 
 
Mean duration of the T1-T2 interval for the Intervention arm was 29 weeks (SD=10.3, median=26, 
range 14-53) and 17 weeks for Control arm (SD=2.9, median=17, range 11-24) (Mann-Whitney -
U=46.0; p<0.001), producing a potential confound to the analyses. The analyses therefore also 
included T1-T2 interval as a covariate. 
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 12
 
RESULTS 
 
Data for the primary and secondary outcome measures at T1 (baseline) and T2 are shown in Table 3. 
The two groups were broadly similar at baseline in terms of symptoms and quality of life reported: 
there were no significant differences between the Intervention and Control arms at T1 on any of the 
primary or secondary outcome measures (p>0.05) after correcting for multiple comparisons on the 
latter. 
 
Table 3: Summary data for primary and secondary outcome measures 
Outcome measure 
Intervention Group  (n = 25) Control group (n = 20) 
T1 T2 T1 T2 
RPQ 34.1 ± 11.4 (100%) 26.3 ± 16.4 (76%) 33.4 ± 9.2 (100%) 27.8 ± 9.0 (95%) 
QOLAS 35.6 ± 6.9 27.0 ± 10.5 36.4 ± 6.7 33.5 ± 8.2 
BICRO-39 85.7 ± 23.1 80.6 ± 24.6 76.5 ± 16.5 80.5 ± 17.3 
- Personal care 2.3 ± 6.3 1.7 ± 3.9 0.2 ± 0.7 0.3 ± 1.1 
- Mobility 7.2 ± 7.4 6.5 ± 6.7 4.4 ± 3.7 5.4 ± 5.2 
- Self-organisation 9.2 ± 8.7 9.0 ± 8.5 7.3 ± 8.0 7.7 ± 7.2 
- Contact (partner/children) 5.7 ± 3.9 5.4 ± 4.4 3.1 ± 3.6 3.8 ± 3.3 
- Contact (parents/siblings) 10.1 ± 3.1 10.5 ± 2.5 9.5 ± 4.7 10.0 ± 3.7 
- Socialising 18.6 ± 5.7 18.8 ± 4.3 19.1 ± 5.0 7.0 ±  5.2 
- Productive employment 16.5 ± 2.8 15.6 ± 3.6 15.7 ± 3.5 15.9 ± 3.7 
- Psychological well-being 16.1 ± 6.4 13.2 ± 6.9 17.3 ± 5.8 17.4 ± 7.0 
HADS-A 9.9 ± 4.8 (44%) 8.9 ± 4.9 (40%) 11.8 ± 3.9 (70%) 11.0 ± 4.1 (55%) 
HADS-D 8.9 ± 4.0 (44%) 7.7 ± 5.0 (28%) 8.9 ± 3.3 (40%) 8.6 ± 4.5 (20%) 
IES-R 27.0 ± 20.1 (32%) 20.8 ± 18.7 (28%) 29.5 ± 20 (40%) 25.3 ± 19.9 (40%) 
CIS20R 98.2 ± 19.5 (76%) 86.8 ± 25 (40%) 104.2 ± 18 (75%) 100.8 ± 26.3 (75%) 
STAXI-2 41.8 ± 14.1 36.7 ± 16 42.1 ± 17.6 40.4 ± 18.0 
MPQ 1.6 ± 1.3 1.7 ± 1.3 1.2 ± 1.0 1.4 ± 0.9 
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EuroQol 57.2 ± 15.9 65.3 ± 16.3* 46.7 ± 15.5 52.7 ± 18.4 
Values are mean ± SD (% above cut-off, where applicable); table shows data for individuals with data at both T1 and 
T2 (n=45); *n=24 due to missing data 
 
Effects of treatment on primary and secondary outcome measures 
A significant treatment effect was noted for quality of life as assessed by the QOLAS (Table 4 & 
Figure 2).  For  postconcussional symptoms (RPQ) the findings were only significant when using T1-
T2 interval as a covariate (Table 4). 
 
No treatment effect was noted in terms of global functioning (BICRO-30). Previous research into 
broader community rehabilitation using the BICRO-39 has indicated individual scales may be more 
sensitive to change than the total score:[49] these scale scores are also given in Table 4. Psychological 
Well-Being and Socialising showed evidence of a treatment effect (the latter only when using T1-T2 
interval as a covariate), with little overall change in the other subscales in either group. 
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Table 4: Analyses of primary and secondary outcome measures, with T1-T2 interval as covariate 
   Without T1-T2 interval as covariate  With T1-T2 interval as covariate 
  T1 (adjusted) T2 (adjusted) 
 
Difference 95% CI  p Effect 
Size 
  T2 (adjusted) 
 
Difference 95% CI  p Effect Size 
   Intervention Control     † ‡  Intervention Control     † ‡ 
Primary RPQ 33.78 26.00 28.10 2.09 (-3.85 to 8.03) F (1, 42) = 
0.51 
0.481 0.012 0.21  23.62 31.07 7.46 (0.42 - 14.50) F (1, 41) = 
4.578 
0.038* 0.100 0.81 
 QOLAS 35.93 27.32 33.11 5.79 (0.97 to 10.61) F (1, 42) = 
5.886 
0.020* 0.123 0.73  25.64 35.21 9.57 (3.78 - 15.37) F (1, 41) = 
11.120 
0.002* 0.213 1.26 
 BICRO-39 81.57 77.87 83.97 6.10 (-4.35 to 16.55) F (1, 42) = 
1.387 
0.245 0.032 0.36  77.56 84.35 6.80 (-6.19 - 19.79) F (1, 41) = 
1.117 
0.297 0.027 0.40 
                    
BICRO 
subscales  
Personal care 1.36 1.56 0.45 -1.12 (-2.96 to 0.73) F (1, 42) = 
1.491 
0.229 0.034 -0.38  1.50 0.53 -0.97 (-3.28 to 1.35) F (1, 41) = 
0.710 
0.414 0.017 -0.32 
 Mobility 5.94 5.74 6.33 0.59 (-2.46 to 3.65) F (1, 42) = 
0.154 
0.697 0.002 0.12  6.26 5.68 -0.57 (-4.32 to 3.1) F (1, 41) = 
0.096 
0.759 0.002 -0.12 
 Self-organisation 8.36 8.45 8.44 0.00 (-3.26 to 3.26) F (1, 42) = 
0.000 
0.998 0.000 0.00  9.10 7.63 -1.47 (-5.52 to 2.58) F (1, 41) = 
0.537 
0.468 0.013 -0.28 
 Contact (partner/children) 4.53 4.52 4.95 0.43 (-1.21 to 2.06) F (1, 42) = 
0.276 
0.602 0.007 0.17  4.15 5.41 1.26 (-0.76 to 3.27) F (1, 41) = 
1.593 
0.214 0.037 0.50 
 Contact (parents/siblings) 9.82 10.29 10.19 -0.10 (-1.25 to 1.04) F (1, 42) = 
0.033 
0.857 0.001 -0.05  10.40 10.05 -0.34 (-1.80 to 1.11) F (1, 41) = 
0.229 
0.635 0.006 -0.18 
 Socialising 18.82 18.86 20.02 1.16 (-1.07 to 3.40) F (1, 42) = 
1.108 
0.299 0.026 0.32  17.83 21.32 3.49 (0.89 to 6.09) F (1, 41) = 
7.325 
0.010* 0.152 1.03 
 Productive employment 16.13 15.26 16.23 0.97 (-0.49 to 2.44) F (1, 42) = 
1.802 
0.187 0.041 0.41  15.34 16.12 0.78 (-1.08 to 2.63) F (1, 41) = 
0.715 
0.403 0.017 0.32 
 Psychological well-being 16.60 13.66 16.77 3.11 (0.42 to 5.81) F (1, 42) = 
5.429 
0.025* 0.114 0.70  12.54 18.18 5.64 (2.49 to 8.80) F (1, 41) = 
13.069 
0.001* 0.242 1.37 
                    
Secondary HADS-A 10.74 9.43 10.37 0.94 (-1.41 to 3.30) F (1, 42) = 
0.654 
0.423 0.015 0.25  8.25 11.84 3.59 (1.03 to 6.15) F (1, 41) = 
8.003 
0.007* 0.163 1.06 
 HADS-D 8.90 7.70 8.62 0.92 (-1.06 to 2.91) F (1, 42) = 
0.882 
0.353 0.021 0.28  7.25 9.19 1.94 (-0.531 to 4.44) F (1, 41) = 
2.513 
0.121 0.058 0.60 
 IES-R 28.11 21.48 24.40 2.92 (-5.49 to 11.32) F (1, 42) = 
0.044 
0.853 0.012 0.26  19.19 27.26 8.06 (-2.28 to 18.41) F (1, 41) = 
2.479 
0.123 0.057 0.59 
 CIS20R 100.82 89.04 97.98 8.94 (-3.48 to 21.36) F (1, 42) = 
2.112 
0.153 0.048 0.44  85.26 102.70 17.44 (2.34 to 32.53) F (1, 41) = 
5.441 
0.025* 0.117 0.89 
 STAXI-2 41.93 36.80 40.30 3.50 (-2.65 to 9.65) F (1, 42) = 
1.317 
0.258 0.030 0.34  34.31 43.41 9.10 (1.826 to 16.370 F (1, 41) = 
6.384 
0.015* 0.135 0.95 
 MPQ 1.40 1.61 1.51 -0.10 (-0.71 to 0.51) F (1, 42) = 
0.112 
0.739 0.003 -0.10  1.57 1.56 -0.12 (-0.78 to 7.52) F (1, 41) = 
0.001 
0.974 0.000 -0.12 
 EuroQol 52.57 69.93 55.59 -7.34 (-17.46 to 2.77) F (1, 41) = 
1.433 
0.238 0.050 -0.47  67.74 49.82 -17.92 (-28.57 to -7.26) F (1, 40) = 
11.555 
0.002* 0.224 -1.31 
*p<0.05; †partial eta squared; ‡Cohen’s dˆ  
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FIGURE 2 AROUND HERE 
 
For secondary outcome measures, treatment effects were only noted after covarying for T1-T2 
interval, for anxiety (HADS-A), fatigue (CIS20R), anger (STAXI-2) and a quality of life (EuroQol). 
These results remained significant after correcting for multiple comparisons. No treatment effects 
were found for depression (HADS-D), symptoms associated with PTSD (IES-R) or pain (MPQ). 
 
Examination of the data indicated that, where T1-T2 interval was a significant covariate, shorter 
intervals were associated with better outcomes. This is illustrated by the data for PCS symptom 
severity (RPQ) (Figure 3) after dividing the Intervention arm into those completing treatment more 
quickly (n=13) and slowly (n=12) based on a median T1-T2 interval split of 188/189 days. Those 
taking longer to complete CBT show little change while those who completed CBT more quickly 
demonstrate larger improvements. This was in contrast to the possibility that a longer interval might 
allow additional time for individuals to show recovery, and be associated with better outcomes. 
 
FIGURE 3 AROUND HERE 
Uncorrected post hoc t-tests on unadjusted means were completed to explore within-group changes 
from T1 to T2 on those measures showing a significant difference between the Intervention and 
Control conditions on ANCOVA at T2 after covarying for treatment duration. For primary outcome 
measures, both the Intervention (t (24)=3.32, p=0.003) and Control (t (19)=4.00, p=0.001)  groups 
showed statistically significant improvements on the RPQ over this period, with a similar results for 
the QOLAS (Intervention: t (24)=4.55, p<0.001; Control: t (19)=2.29, p=0.034). The Intervention 
group showed a significant improvement on the Psychological Well-Being subscale from the BICRO 
(t (24)=2.99, p=0.006), whereas the Control group did not (t (19)=0.12, p=0.197). Neither group 
showed evidence of significant improvement on Socialising on the BICRO (Intervention: t (24)=0.12, 
p=0.903; Control: t (19)=1.35, p=0.197). For secondary outcome measures, the Intervention group 
showed significant improvements on the CIS-20R (t (24)= 2.91, p=0.008), STAXI-2 (t (24)= 2.20, 
p=0.038) and EuroQol (t (23)=2.18, p=0.040),  whilst the Controls did not show any improvements 
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on these variables (t (19)=0.71, p=0.785; t (19)= 0.90, p=0.382; t (19)= 1.58, p=0.132). Neither group 
showed evidence of significant improvement on HADS-A (Intervention: t (24)=1.01, p=0.323; 
Control: t (19)=1.18, p=0.253). 
 
Factors moderating treatment effects 
To explore the possible influence of other factors on improvements in the Intervention group, data 
from the QOLAS was examined, as it showed the largest effects of treatment. Those factors used as 
minimisation variables at randomisation were considered separately as additional categorical factors: 
data stratified by these variables is shown in Table 5. Neither injury severity (F (2)=0.33; p=0.72), 
length of time since injury (F (2)=1.09; p=0.36), medicolegal status (F (1)=1.20; p=0.29), nor 
treatment site (F (1)=0.02; p=0.90) were related to outcome. Current (as opposed to either previous or 
current) medicolegal involvement was also unrelated to outcome (F (1)=0.19; p=0.67). 
 
Table 5: Summary data for QOLAS, stratified by TBI severity, length of time since injury and 
medicolegal status 
 Intervention Group   Control group 
n T1 T2 n T1 T2 
TBI severity       
Mild 12 34.0 ± 8.3 24.5 ± 12.0 12 35.8 ± 6.8 32.7 ± 9.9 
Moderate  7 37.1 ± 6.0 28.2 ± 8.2 5 37.4 ± 6.9 34.1 ± 3.9 
Severe  6 36.9 ± 4.7 30.6 ± 10.1 3 37.2 ± 8.4 35.7 ± 8.0 
Time since injury       
6 – 12 months 6 34.9 ± 7.9 21.7 ± 10.0 7 36.6 ± 4.7 33.9 ± 4.8 
≤ 24 months 5 30.0 ± 7.0 24.1 ± 7.9  3 34.8 ± 4.4  27.5 ± 11.8  
> 24 months 14 37.8 ± 5.5 30.4 ± 10.8 10  36.8 ± 8.6 35.0 ± 9.1 
Medicolegal status       
Previous/current 19 36.7 ± 7.0 28.9 ± 9.4 14 36.0 ± 7.4 33.4 ± 8.9 
Page 16 of 35
https://mc.manuscriptcentral.com/jnnp
Journal of Neurology, Neurosurgery, and Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 
 17
None 6 32.0 ± 5.4 20.9 ± 12.4  6 37.3 ± 5.0 33.8 ± 7.2 
Values are shown as mean ± SD; table shows data for individuals with data at both T1 and T2 (n=45) 
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DISCUSSION 
 
This study, consistent with positive findings from a previous RCT,[24] found that individual CBT 
improved the quality of life for patients with persistent postconcussional symptoms.  CBT also 
appeared to be effective in alleviating postconcussional symptoms in those patients who completed 
treatment more quickly. Possible benefits on a range of secondary outcomes including anxiety, fatigue 
and anger were also noted, albeit only after treatment duration was considered as a covariate. Some 
outcome measures showed medium to large effect sizes from before to after treatment, although the 
mean scores of the CBT group indicated that a majority of patients were not symptom- or problem-
free at the end of treatment (as with the previous trial[24]), although 24% of treatment completers fell 
below a proposed clinical cut-off of 12 or less on the RPQ.[33] The current study also demonstrates 
that clinical improvement in PCS is possible using CBT without an explicit cognitive remediation 
component, and with a programme of only 12 hours of patient-therapist contact. Contrary to 
expectations, neither medicolegal status, injury severity nor length of time since injury had significant 
effects on improvements in the CBT group. 
 
Of the outcome measures used, the QOLAS gave the most robust evidence for an effect of CBT, 
perhaps because it captured specific symptoms identified by the patient as directly relevant to their 
quality of life. Its identification of “key” problem areas also helped identify personal treatment targets 
for therapy, increasing its sensitivity to change and its clinical utility. The potential advantages for 
individualised patient reported outcome measures and their responsiveness to change has led to their 
appearance into brain injury rehabilitation via methods such as Goal Attainment Scaling.[49]  
 
Contrary to expectations that persistent symptoms are static or may even worsen with time, 
individuals in the control group did show evidence of improvements over their waiting list period in 
terms of postconcussional symptoms (RPQ) and their impact on quality of life (QOLAS). The 
neuropsychiatric and neuropsychological assessment, feedback and prospect of either immediate or 
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 19
delayed treatment may have contributed to this change, by providing a coherent possible explanation 
for symptoms and offering hope that change and improvement was possible.[50] 
 
There was no evidence for significant effects of treatment on depression or PTSD, both of which have 
been linked with PCS.[9] This may have been due to floor effects as less than 50% of individuals 
scored above clinical cut-offs on the HADS-Depression and RIES at the initial assessment. However, 
the results imply that general improvement in PCS and quality of life were not simply mediated by 
improved mood.  
 
The impact of the time taken to complete CBT was noteworthy. Not using treatment duration as a 
covariate removed positive group differences for postconcussional symptoms (as measured by the 
RPQ), although those for quality of life (QOLAS and BICRO-Psychological Well-Being) remained. 
Session frequency may be a factor, with evidence that increased intensity may be associated with 
better outcomes in psychological therapies in other areas,[51] although this may not always be the 
case.[52] Faster completion may also have indicated greater engagement to therapy. Although the 
large majority completed therapy, a longer time to complete the CBT sessions was often due to 
patients repeatedly cancelling and re-arranging appointments, perhaps reflecting lower commitment. 
Whatever the source of this effect, it does indicate that there may be significant variability between 
individuals with persistent PCS in their treatment response to CBT. 
 
Caution should be exercised in the interpretation of the null results from the moderator analyses 
examining the impact of variables possibly affecting treatment response, such as injury severity and 
medicolegal status. The relationship between injury severity and treatment response may be complex: 
a residential programme focussing on treating PTSD in military veterans found that individuals with 
moderate-severe TBIs showed greater improvements in their PTSD symptoms compared with those 
with mild TBIs.[53] Although compensation seeking has been associated with increased symptom 
report even after early intervention,[54] medicolegal status itself may serve as a poor proxy for 
phenomena such as poor effort or malingering in neuropsychological assessments.[55] The latter is 
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more likely to affect treatment outcome, but formal cognitive measures of effort were not available 
for all participants. More generally, the smaller subgroups used and the corresponding decrease in 
power may well have obscured modest influences on treatment outcome, and precluded examining 
possible interactions such as medicolegal status playing a more significant role in influencing 
outcome in mild but not severe TBI.[8] Nonetheless, the null results for variables that might be 
expected to affect treatment outcomes suggests that they may not be major determinants of 
improvement in CBT, at least for the individuals seen in the current trial. 
 
Study limitations 
The variation in time taken to complete the sessions of CBT (with the CBT group taking longer to 
complete their treatment than the interval spent on waiting list in the control group) was undesirable, 
although the alternative of having a fixed assessment interval regardless of the completeness of 
treatment imposes its own difficulties. Use of a cross-over waiting list design complicates the 
controlled assessment of the maintenance of therapy benefits and longer-term outcome. Data on other 
variables that might have influenced outcomes (such as homework completion, or perceptions of the 
usefulness of treatment) were not collected. 
 
Another limitation stems from the use of a single therapist combined with individualised treatment. 
Although fitting the needs of patients, rather using a highly manualised protocol, generalisability of 
the findings may be limited by the therapist’s expertise. Whilst typical of clinical practice, completion 
of study questionnaires given by the treating therapist may also contribute a potential response bias. 
Future larger/multicentre studies may usefully include a measure of therapist competence and 
protocol adherence, and outcome measures given by a non-treating researcher.  
 
Conclusions 
The current trial adds to the sparse evidence that the impact of persistent PCS, especially on 
individuals’ quality of life, can be ameliorated even for individuals sustaining more-than-mild TBIs. 
Individual differences in treatment response were noted, as indicated by the impact of treatment 
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duration, and some treatment effects were only statistically significant after controlling for this 
variable.  An explicit, concomitant cognitive rehabilitation component did not appear necessary for 
these improvements: further work is needed to examine the value of this approach with or without 
CBT, whether certain symptoms respond differently to different treatment types, and how best to 
integrate different treatments both practically and theoretically. As research into psychological factors 
affecting the development and maintenance of persistent PCS continues, understanding the role of 
variables such as coping,[11] symptom and injury perceptions,[10,11] and broader personality 
traits[2] may also help in refining CBT interventions and identifying mediators and moderators of 
change.[16] 
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Figure 2: QOLAS total score at baseline (T1) and follow-up (T2) 
Figure 3: RPQ total score at baseline (T1) and follow-up (T2), with Intervention group median-split 
according to T1-T2 interval 
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SUPPLEMENTARY ONLINE MATERIAL: ADDITIONAL INFORMATION ABOUT 
CBT PROTOCOL 
 
Two psychoeducation information booklets were used. The first was a general introduction to 
PCS based on the material of Mittenberg, Zielinski and Fichera,[1] which reviewed common 
postconcussional symptoms, expected course of recovery, and the possible role of vicious 
cycles in maintaining persistent symptoms. The second booklet focussed on cognitive 
difficulties and reasons why they might persist after a brain injury (including the role of 
stress, effort and over-exertion);[2] the role of confidence in memory and other cognitive 
domains, and the impact of mood, rumination and worry;[3] and the possible effects of 
elements of perfectionism[4,5] and reinvestment.[6]  
 
Where formulations identified overlap with relevant conditions such as anxiety and 
depression, cognitive-behavioural techniques used were  based on the work of Beck,[7] and 
Hawton and colleagues,[8] and utilised modifications for chronic fatigue syndrome,[9] 
PTSD[10] and perfectionism[5] when appropriate. 
 
Behavioural components included work on sleep hygiene[8] and behavioural activation,[11] 
with a particular focus on making sustainable increases in activity over time avoiding “boom-
and-bust”,[9] as well as addressing possible avoidance and procrastination[12].  
 
Cognitive approaches included negative automatic and dysfunctional thoughts records in 
responses to symptoms, explored through Socratic questioning, and challenged/tested 
particular through verbal reattribution techniques or behavioural experiments. A focus on 
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beliefs about symptom causes was typically avoided in favour of broader attributions and 
implications such as catastrophic misinterpretations to cognitive errors.  
 
Metacognitive beliefs were often an explicit target in the sessions. Amongst other homework 
tasks, patients were often encouraged to keep positive data logs[13] to keep track of cognitive 
or other successes, to modify attentional bias towards mistakes or failures and build 
confidence. 
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Figure 1: CONSORT flow diagram of patient progress through trial  
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Figure 2: QOLAS total score at baseline (T1) and follow-up (T2)  
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Figure 3: RPQ total score at baseline (T1) and follow-up (T2), with Intervention group median-split 
according to T1-T2 interval  
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